Skip to main content
SpringerLink
Log in

Infections in the Kidney Transplant Recipient

  • Chapter
Dermatological Manifestations of Kidney Disease

  • 1063 Accesses

Abstract

Transplant recipients are at higher risk for a wide variety of severe infections, including skin and disseminated disease, due to immunosuppression. Fungal infections are especially common and can range from slight scale on the feet to life-threatening multisystem disease. Fungal infections in humans can be divided into three main groups based on tissue invasion and host characteristics: superficial cutaneous, subcutaneous, and opportunistic. Each has the potential to complicate the management of a renal transplant patient. A high index of suspicion is required to identify potential fungal infections in these patients. With proper awareness, the vast majority of fungal infections can be identified and successfully treated. This chapter primarily reviews the common fungal infections, their clinical characteristics, strategies for diagnosing fungal infections, and treatment of the more common infections. Other opportunistic infections are included for completeness but will not be covered in depth.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Brasch J. Current knowledge of host response in human tinea. Mycoses. 2009;52(4):304–12.

    Article  CAS  PubMed  Google Scholar 

  2. Chotirmall SH, Al-Alawi M, Mirkovic B, et al. Aspergillus-associated airway disease, inflammation, and the innate immune response. Biomed Res Int. 2013;2013:723129.

    Article  PubMed Central  PubMed  Google Scholar 

  3. Mansour MK, Tam JM, Vyas JM. The cell biology of the innate immune response to Aspergillus fumigatus. Ann N Y Acad Sci. 2012;1273:78–84.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Foster KW, Ghannoum MA, Elewski BE. Epidemiologic surveillance of cutaneous fungal infection in the united states from 1999 to 2002. J Am Acad Dermatol. 2004;50(5):748–52.

    Article  PubMed  Google Scholar 

  5. Summerbell RC, Kane J, Krajden S. Onychomycosis, tinea pedis and tinea manuum caused by non-dermatophytic filamentous fungi. Mycoses. 1989;32(12):609–19.

    Article  CAS  PubMed  Google Scholar 

  6. Kelly BP. Superficial fungal infections. Pediatr Rev. 2012;33(4):e22–37.

    Article  PubMed  Google Scholar 

  7. Elewski BE. Onychomycosis: pathogenesis, diagnosis, and management. Clin Microbiol Rev. 1998;11(3):415–29.

    CAS  PubMed Central  PubMed  Google Scholar 

  8. Daniel III CR, Norton LA, Scher RK. The spectrum of nail disease in patients with human immunodeficiency virus infection. J Am Acad Dermatol. 1992;27(1):93–7.

    Article  PubMed  Google Scholar 

  9. Roman AD, Salvana EM, Guzman-Penamora MA, Roxas EA, Leyritana KT, Saniel MC. Invasive trichosporonosis in an AIDS patient: case report and review of the literature. Int J STD AIDS. 2014;25(1):70–5.

    Article  PubMed  Google Scholar 

  10. Brasch J, Morig A, Neumann B. Proksch E. Mycoses: Expression of antimicrobial peptides and toll-like receptors is increased in tinea and pityriasis versicolor; 2013.

    Google Scholar 

  11. Correia RT, Valente NY, Criado PR, Martins JE. Chromoblastomycosis: study of 27 cases and review of medical literature. An Bras Dermatol. 2010;85(4):448–54.

    Article  PubMed  Google Scholar 

  12. Bonifaz A, Vazquez-Gonzalez D. Sporotrichosis: an update. G Ital Dermatol Venereol. 2010;145(5):659–73.

    CAS  PubMed  Google Scholar 

  13. van Belkum A, Fahal A, van de Sande WW. Mycetoma caused by Madurella mycetomatis: a completely neglected medico-social dilemma. Adv Exp Med Biol. 2013;764:179–89.

    Article  PubMed  Google Scholar 

  14. Pappas PG. Invasive candidiasis. Infect Dis Clin North Am. 2006;20(3):485–506.

    Article  PubMed  Google Scholar 

  15. Ben-Ami R, Lewis RE, Kontoyiannis DP. Enemy of the (immunosuppressed) state: an update on the pathogenesis of Aspergillus fumigatus infection. Br J Haematol. 2010;150(4):406–17.

    CAS  PubMed  Google Scholar 

  16. Ibrahim AS, Spellberg B, Walsh TJ, Kontoyiannis DP. Pathogenesis of mucormycosis. Clin Infect Dis. 2012;54 Suppl 1:S16–22.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  17. Reyes HM, Tingle EJ, Fenves AZ, Spiegel J, Burton EC. Pulmonary invasive mucormycosis in a patient with secondary iron overload following deferoxamine therapy. Proc (Bayl Univ Med Cent). 2008;21(4):378–81.

    Google Scholar 

  18. Revankar SG. Phaeohyphomycosis. Infect Dis Clin North Am. 2006;20(3):609–20.

    Article  PubMed  Google Scholar 

  19. Bourgeois GP, Cafardi JA, Sellheyer K, Andea AA. Disseminated fusarium infection originating from paronychia in a neutropenic patient: a case report and review of the literature. Cutis. 2010;85(4):191–4.

    PubMed Central  PubMed  Google Scholar 

  20. Nong S, Liang J. Bone marrow Penicillium marneffei infection in acquired immunodeficiency syndrome patients: report of 35 cases. Trop Biomed. 2013;30(1):89–91.

    CAS  PubMed  Google Scholar 

  21. Queipo JA, Broseta E, Santos M, Sanchez-Plumed J, Budia A, Jimenez-Cruz F. Mycobacterial infection in a series of 1261 renal transplant recipients. Clin Microbiol Infect. 2003;9:518–25.

    Article  CAS  PubMed  Google Scholar 

  22. Gupta AK, Tu LQ. Dermatophytes: diagnosis and treatment. J Am Acad Dermatol. 2006;54(6):1050–5.

    Article  PubMed  Google Scholar 

  23. Ortega-Loayza AG, McCall CO. Images in clinical medicine. Cutaneous blastomycosis. N Engl J Med. 2013;368(10):e13.

    Article  PubMed  Google Scholar 

  24. Smith EB. The treatment of dermatophytosis: safety considerations. J Am Acad Dermatol. 2000;43(5):S113–9.

    Article  CAS  PubMed  Google Scholar 

  25. Lesher JL. Medscape.com [homepage on the Internet]. Elston DM, editor. http://emedicine.medscape.com/article/1091473-treatment.

  26. Phillips RM, Rosen T. Topical antifungal agents. In: Wolverton SE, editor. Comprehensive dermatologic drug therapy. 3rd ed. Philadelphia, PA: Elsevier Saunders; 2012.

    Google Scholar 

  27. Food and Drug Administration [Internet] Washington, D.C. MedWatch The FDA Safety Information and Adverse Event Reporting Program.Nizoral (ketoconazole): drug safety communication – potentially fatal liver injury, risk of drug interactions and adrenal gland problems [Posted 07/26/2013]. http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm362672.htm.

  28. Epocrates Online [homepage on the Internet] San Mateo, CA. https://online.epocrates.com.

  29. Lamisil (terbinafine hydrochloride tablet) [package insert] East Hanover, NJ: Novartis Pharmaceuticals Corp.; Revised 6/2013. https://www.pharma.us.novartis.com/product/pi/pdf/Lamisil_tablets.pdf.

  30. Lamisil (terbinafine hydrochloride tablet) [package insert] East Hanover, NJ: Novartis Pharmaceuticals Corp.; Revised 6/2013. http://www.pharma.us.novartis.com/product/pi/pdf/Lamisil_Oral_Granules.pdf.

  31. Sporanox (itraconazole capsule) [package insert] Raritan, NJ: Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Revised 6/2012. http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a4d555fa-787c-40fb-bb7d-b0d4f7318fd0.

  32. Diflucan (fluconazole tablets) [package insert] New York, NY: Pfizer Inc.; Revised 3/2013. http://labeling.pfizer.com/ShowLabeling.aspx?id=575.

  33. Grifulvin V (griseofulvin microsize) [package insert] Los Angles, CA: Ortho Dermatologics; Revised 8/2013. http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6149c044-58bb-402c-a4b5-18b96dd9b3b9.

  34. Nizoral (ketoconazole tablet) [package insert] Titusville, NJ: Janssen Pharmaceuticals, Inc.; Revised 7/2013. http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=090660c1-6e6d-457f-adb5-046ddfcd1465.

  35. VFEND (voriconazole tablets) [package insert] New York, NY: Pfizer Inc.; Revised 11/2011. http://labeling.pfizer.com/ShowLabeling.aspx?id=618.

  36. Miller DD, Cowen EW, Nguyen JC, McCalmont TH, Fox LP. Melanoma associated with long-term voriconazole therapy. Arch Dermatol. 2012;146(3):300–4.

    Google Scholar 

  37. Clancy CJ, Nguyen MH. Long-term voriconazole and skin cancer: is there cause for concern? Curr Infect Dis Rep. 2011;13:536–43.

    Article  PubMed  Google Scholar 

  38. Noxafil (posaconazole oral suspension) [package insert] Whitehouse Station, NJ: Merck & Co., Inc.; Revised 12/2012. http://www.merck.com/product/usa/pi_circulars/n/noxafil/noxafil_pi.pdf.

  39. Gupta AK. Systemic antifungal agents. In: Wolverton SE, editor. Comprehensive dermatologic drug therapy. 3rd ed. Philadelphia, PA: Elsevier Saunders; 2012.

    Google Scholar 

  40. Schwartz RA. Medscape.com [homepage on the Internet]. Majocchi granuloma. Elston DM, editor. http://emedicine.medscape.com/article/1092601-treatment.

  41. Moossavi M, Bagheri B, Scher RK. Systemic antifungal therapy. Dermatol Clin. 2001;19(1):35–52.

    Article  CAS  PubMed  Google Scholar 

  42. Burkhart CG. Medscape.com [homepage on the Internet]. Tinea versicolor. Elston DM, editor. http://emedicine.medscape.com/article/1091575-treatment.

  43. Elewski BE, Hughey LC, Sobera JO, Hay R. Fungal diseases. In: Bolognia JL, Jorizzo JL, Schaffer JV, editors. Dermatology. 3rd ed. Philadelphia, PA: Elsevier Saunders; 2012.

    Google Scholar 

  44. James WD, Berger TG, Elston DM. Andrews’ diseases of the skin. 11th ed. Philadelphia, PA: Elsevier Saunders; 2011.

    Google Scholar 

  45. Schwartz RA. Medscape.com [homepage on the Internet]. Elston DM, editor.http://emedicine.medscape.com/article/1092695-treatment#1.

  46. Tan H-H, Goh C-L. Viral infections affecting the skin in organ transplant recipients. Am J Clin Dermatol. 2006;7:13–29.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Virginia Commonwealth University Health System, 401 N. 11th Street, Suite 520, Nelson Clinic, 980164, Richmond, VA, 23298, USA

    James D. Russell M.D. & Calvin O. McCall M.D.

  2. Dermatology Section, VA Medical Center, Richmond, Richmond, VA, 23298, USA

    Calvin O. McCall M.D.

Authors
  1. James D. Russell M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Calvin O. McCall M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Calvin O. McCall M.D. .

Editor information

Editors and Affiliations

  1. Department of Dermatology, Nelson Clinic, Virginia Commonwealth University Medical Center, Richmond, Virginia, USA

    Julia R. Nunley

  2. Department of Medicine, Section of Nephrology, University of Illinois at Chicago / Advocate Christ Medical Center, Oak Lawn, Illinois, USA

    Edgar V. Lerma

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Russell, J.D., McCall, C.O. (2015). Infections in the Kidney Transplant Recipient. In: Nunley, J., Lerma, E. (eds) Dermatological Manifestations of Kidney Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2395-3_17

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-2395-3_17

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-2394-6

  • Online ISBN: 978-1-4939-2395-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation